COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,676 Articles (22,913 medRxiv, 8,763 bioRxiv)

Most recent first Previous |  Page 648: Articles 6471-6480  | Next

Impact of COVID-19 on mortality in coastal Kenya: a longitudinal open cohort study
Otiende, M. O., Nyaguara, A., Bottomley, C., Walumbe, D., Mochamah, G., Amadi, D., Nyundo, C., Kagucia, E., Etyang', A., Adetifa, I., Brand, S. P., Maitha, E., Chondo, E., Nzomo, E., Aman, R., Mwangangi, M., Amoth, P., Kasera, K., Ng'ang'a, W., Barasa, E., Tsofa, B., Mwangangi, J., Bejon, P., Agweyu, A., Williams, T., Scott, A.
10.1101/2022.10.12.22281019 — Posted: 2022-10-13
Real-time surveillance of international SARS-CoV-2 prevalence using systematic traveller arrival screening
Kucharski, A., Chung, K., Aubry, M., Teiti, I., Teissier, A., Richard, V., Russell, T., Bos, R., Olivier, S., Cao-Lormeau, V.-M.
10.1101/2022.10.12.22280928 — Posted: 2022-10-13
Quantifying changes in the IFR and IHR over 23 months of the SARS-CoV-2 pandemic in England
Eales, O., Haw, D., Wang, H., Atchison, C., Ashby, D., Cooke, G., Barclay, W., Ward, H., Darzi, A., Donnelly, C. A., Chadeau-Hyam, M., Elliott, P., Riley, S.
10.1101/2022.10.12.22281016 — Posted: 2022-10-13
Cytosolic Proliferating Cell Nuclear Antigen (PCNA) interacts with S100A8 and controls an inflammatory subset of neutrophils in COVID-19
Formiga, R., Pesenti, L., Ladjemi, M. Z., Andrieu, M., Many, S., Karunanithy, V., Bailly, K., Dhote, T., Starick, M., Lummertz da Rocha, E., Puig Lombardi, E., Frachet, P., Granger, V., de Chaisemartin, L., Chollet-Martin, S., Mouthon, L., Spiller, F., Hosmalin, A., Hurtado-Nedelec, M., Martin, C., Pene, F., Burgel, P.-R., Tourneur, L., Witko-Sarsat, V.
10.1101/2022.10.12.22280984 — Posted: 2022-10-13
Analysis of fatality among COVID-19 cases in Mexican pregnant women: a cross-sectional study
Padilla-Raygoza, N., Gallardo-Luna, M. d. J., Flores-Vargas, G., Navarro-Olivos, E., Magos-Vazquez, F. J., Lara-Lona, E., Diaz-Martinez, D. A.
10.1101/2022.10.12.22280996 — Posted: 2022-10-12
SARS-CoV2 associated secretion of nanoLuciferase reports on virus and Virus-Like Particle production
Gullberg, R., Frydman, J.
10.1101/2022.10.11.511764 — Posted: 2022-10-12
Post-acute symptoms four months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study
Spiliopoulos, L., Sorensen, A. I. V., Bager, P. M., Munk Nielsen, N., Vinslov Hansen, J., Koch, A., Meder, I. K., Videbech, P., Ethelberg, S., Hviid, A. P.
10.1101/2022.10.12.22280990 — Posted: 2022-10-12
Discovering hub genes involved in the pathophysiological impact of COVID-19 on diabetes kidney disease by differential gene expression and interactome analysis
Osuna Martinez, U., Avina-Padilla, K., Olimon-Andalon, V., Angulo, C., Guadron-Llanos, A., Rivas-Ferreira, J. C., Urrea, F., Calderon-Zamora, L.
10.1101/2022.10.11.511826 — Posted: 2022-10-12
Alterations in platelet proteome signature and impaired platelet integrin αIIbβ3 activation in patients with COVID-19
Goudswaard, L. J., Williams, C. M., Khalil, J., Burley, K. L., Hamilton, F., Arnold, D., Milne, A., Lewis, P. A., Heesom, K. J., Mundell, S. J., Davidson, A. D., Poole, A. W., Hers, I.
10.1101/2022.10.12.511145 — Posted: 2022-10-12
Development of SARS-CoV-2 replicons for the ancestral virus and variant of concern Delta for antiviral screening.
Erdmann, M., Kavanagh Williamson, M., Jearanaiwitayakul, T., Bazire, J., Matthews, D. A., Davidson, A. D.
10.1101/2022.10.11.511804 — Posted: 2022-10-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).